Head-to-head · Value Score
Trimi Health vs Freya Meds
Two GLP-1 deals, scored on the same six factors. Trimi Health lands a Value Score of 89, Freya Meds a 64. Here's who gives you the honest lower price — and where each one bites back.
Trimi Health
#3 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameFreya Meds
#321 · Grade C · Watch List
Est. first month
From $250/mo (quarterly plan, compounded)
Save ~81% vs brand-nameThe verdict
Trimi Health takes it on Value Score, 89 to 64 — an est. $99/mo first month, with no teaser step-up baked in. Freya Meds isn't out of it: Patients wanting dietitian-supported compounded GLP-1 programs.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Trimi Health | Freya Meds |
|---|---|---|
| Value Score | 89 (A) | 64 (C) |
| Est. first month | $99/mo | From $250/mo (quarterly plan, compounded) |
| Save vs brand-name | ~93% | ~81% |
| Semaglutide | $99/mo | From $250/mo (quarterly plan, compounded) |
| Tirzepatide | $125/mo | From $332/mo (quarterly plan, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Trimi Health
The ultra-budget pick: two-digit semaglutide and a $125 tirzepatide — one of the lowest flat tirz stickers on the whole board — shipped to all 50 states.
Why it's a deal
- Ultra-budget on both molecules — $99 semaglutide and a class-low $125 tirzepatide, flat with no teaser step-up
- Tirzepatide at $125/mo undercuts most of the flat-fee field on the priciest molecule
- Nationwide 50-state reach, so the low price isn't gated to a handful of states
The fine print
- Not LegitScript-certified — do your own pharmacy diligence before you buy on price alone
- Compounded injectable only — no FDA-approved brand-name or oral/sublingual route
- Newer brand with a thin public track record
Freya Meds
Freya Meds is a GLP-1 specialist offering compounded semaglutide ($250–$297/mo) and compounded tirzepatide ($332–$390/mo).
Why it's a deal
- GLP-1 specialist — not a multi-category telehealth
- Price includes unlimited doctor consultations, monthly group calls, and a dietitian consultation
- Both semaglutide and tirzepatide available
- Multi-month discount on quarterly billing
- Claims 450,000+ enrolled
The fine print
- No visible LegitScript or PCAB accreditation
- Above-average pricing ($250–$390/mo)
- Compounded only — no brand-name options
- Now serves 49 U.S. states (one state excluded; specific exclusion not named)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Trimi Health is ranked on the Trimi Health alternatives board, and the same list for the other side is on alternatives to Freya Meds.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.